Back

Vascular involvement in loyes-dietz syndrome: distribution and prevalence of aneurysms and dissections across different vascular territories

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Hereditary connective tissue disorders Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Luke Dreher

Mayo Clinic, Scottsdale (United States of America)

6 More presentations in this session

Presentation thumbnail
Exploration of cyclophilin A antibody anti-eCypA as a new approach in the treatment of marfan syndrome
Ms H. Witthaus (Kiel, DE)
Abstract Slides Video
Presentation thumbnail
Health-related quality of life is impaired in marfan syndrome and is strongly associated with lower exercise capacity
Doctor G. Teixido Tura (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Evaluation of the impact of a cardiac rehabilitation program on exercise capacity and cardiocirculatory parameters in patients with Marfan syndrome
Doctor C. Badia Molins (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
Evaluation of exercise capacity and cardiovascular parameters through cardiopulmonary exercise testing in patients with Marfan syndrome.
Doctor A. Hernandez-Pineda (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Phenotypical variability beyond the genotype/phenotype correlation in patients with FBN1 pathogenic variant
Doctor G. Jondeau (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Hereditary connective tissue disorders

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiac interventions in Loeys-Dietz syndrome: insights into clinical management and outcomes
thumbnail
Congress Presentation
IPSC-derived vascular smooth muscle cell model recapitulates Loeys-Dietz-Syndrome type V aortic phenotype
thumbnail
Congress Presentation
A diagnosis of vascular ehlers-danlos syndrome in childhood: clinical and molecular features of 63 individuals

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources